Morgan Stanley’s iShares Health Innovation Active ETF BMED Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-710
Closed -$18.7K – 7858
2024
Q1
$18.7K Buy
+710
New +$18K ﹤0.01% 6510

Other funds holding BMED

Morgan Stanley's BMED Position: Q2 2024 in Review

Morgan Stanley sold out of iShares Health Innovation Active ETF (BMED) in Q2 2024, closing a stake of 710 shares — an estimated $18.7K sold.

Morgan Stanley first reported a position in BMED in Q1 2024 and held it in 1 quarter. The position peaked at $18.7K in Q1 2024. 5 funds tracked by Wall St. Rank hold BMED as of Q2 2024.

  • Morgan Stanley reported no remaining iShares Health Innovation Active ETF position as of Q2 2024 after selling out during the quarter.
  • Morgan Stanley sold 710 iShares Health Innovation Active ETF shares in Q2 2024, an estimated $18.7K.
  • Morgan Stanley first reported a position in iShares Health Innovation Active ETF in Q1 2024 and held it in 1 quarter.
  • Morgan Stanley's iShares Health Innovation Active ETF position peaked at $18.7K in Q1 2024.
  • 5 funds tracked by Wall St. Rank held iShares Health Innovation Active ETF as of Q2 2024.

Based on Morgan Stanley's 13F filing for Q2 2024, filed 14 Aug 2024.